Microbioz India: February 2021 Medical edition

Nebulization is a common and alternative method of drug delivery to the lungs. It is largely used in clinical settings for the treatment of acute respiratory ailments as well as for the long-term treatment of obstructive airway diseases such as chronic obstructive pulmonary disease, asthma, cystic fibrosis and bronchiectasis.
The cover story of this month titled “Nebulization is safe, say experts” contributed by Mediawire a case study which mainly focuses on Nebulization safe practices, the article explains the view of Indian Chest Society (ICS), over the use of Nebulization, the apex body of pulmonologists in India, appointed a task force to gather all the updated available evidence to come out with a guidance document for physicians. The said guidance was recently made available online ahead of print.
Added to this, the magazine has a unique article as a case study of Aster Hospital entitled “High Efficiency Aerosol Drug Delivery During Ventilation” contributed by Aerogen-Pioneering Aerosol Drug Delivery. Aerogen devices are highly efficient vibrating mesh aerosol drug delivery systems which can be used inline during any type of respiratory support including mechanical ventilation, high frequency oscillatory ventilation (HFOV), non-invasive ventilation (NIV), continuous positive airway pressure (CPAP) and High Flow Nasal Cannula (HFNC)1-4, 7, 20, 23.

Keywords: Nebulization,COPD,respiratory illness,lung infection